Herrengasse 6-8 /3/5 1010 Vienna – Austria
INDICATIONS1
For the full list of excipients, see section 6.1 of the product information 05/2024
Method of administration:
Giapreza is indicated for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies, see section 5.1 of the product Information 05/2024.
1Giapreza® Summary of Product Characteristics, as of 05/2024
You can find the product information on the website of the European Medicines Agency here.